Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ayushi Verma
Observed name:
A. Verma
Institution:
Central Drug Research Institute
Observed institutions:
Central Salt and Marine Chemicals Research Institute,
Central Drug Research Institute,
Council of Scientific and Industrial Research
ORCID:
0009-0007-0600-1978
Observed ORCID:
0009-0007-0600-1978
OpenAlex ID:
A5002597274
ACSL4-mediated H3K9 and H3K27 hyperacetylation upregulates SNAIL to drive TNBC metastasis
2024
·
Abhipsa Sinha
, Krishan Kumar Saini
, et al.
·
Proceedings of the National Academy of Sciences
·
28
Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
·
Cancer Research Communications
·
17
Emerging role of EZH2 in solid tumor metastasis
2024
·
Ayushi Verma
, Muqtada Ali Khan
, et al.
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
6
Structural Dynamics, Evolutionary Significance, and Functions of Really Interesting New Gene Proteins in Ubiquitination and Plant Stress: A Review
2025
·
Parinita Agarwal
, Anjali Chittora
, et al.
·
DNA and Cell Biology
·
4
Targeting EZH2 and EGFR therapeutic vulnerabilities of TNBC with a single chemical entity confers preclinical treatment advantage
2026
·
Saumya Ranjan Satrusal
, Arpita Banerjee
, et al.
·
Molecular Therapy
Pan-cancer single-cell analysis identifies a FOXF1/FOXF2-associated transitional CAF-like fibroblast state
2026
·
Bayrta Mandzhieva
, Ayushi Verma
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
AI-Informed neoantigen prioritization enables a multi-epitope mRNA/LNP vaccine with antigen-specific immunogenicity and antitumor activity
2026
·
Ayushi Verma
, Sang Hoon Kim
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
ACSL4 activity drives TNBC metastasis by positively regulating Histone H3 Acetylation mediated SNAIL expression
2023
·
Abhipsa Sinha
, Krishan Kumar Saini
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Supplementary Figure S1 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
PDF
FIGURE 3 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
FIGURE 4 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
Supplementary Figure S5 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
PDF
FIGURE 1 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
Supplementary Table S2 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
Supplementary Figure S4 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
Supplementary Figure S1 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
FIGURE 7 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
FIGURE 2 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
Supplementary Table S1 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
FIGURE 1 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
Supplementary Methods from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
PDF
Supplementary Table S1 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
Supplementary Figure S2 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
PDF
Supplementary Figure S7 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
FIGURE 6 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023
·
Anjali Yadav
, Tanay Biswas
, et al.
Show more works
View as search
Works count:
49
Citation count:
55
H-index:
4
I10-index:
2
Year
Topic
Type